DrugPatentWatch Database Preview
« Back to Dashboard
Amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfateis the generic ingredient in sixteen branded drugs marketed by Shire, Actavis Elizabeth, Impax Labs, Teva, Barr Labs Inc, Shire Dev Llc, Teva Womens, Alvogen Malta, Aurolife Pharma Llc, Barr, Epic Pharma Llc, Mylan Pharms Inc, Nesher Pharms, Nuvo Pharm, Sandoz, Specgx Llc, Sun Pharm Industries, and Teva Pharms, and is included in twenty NDAs. There are ten patents protecting this compound and three Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.
There are fifty-four drug master file entries for amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. Twenty-two suppliers are listed for this compound.